This book offers a complete overview on non colorectal non neuroendocrine (NCRNNE) liver metastases and describes in detail the currently available therapies. Each chapter focuses on the treatment of metastases from a particular primary malignancy and also provides valuable information on incidence, natural history and diagnosis. NCRNNE liver metastases are rare entities compared with colorectal and neuroendocrine metastases, for which the treatments are well codified. While more publications have appeared on the topic in recent years, an in-depth study has to date been lacking. Furthermore, most published series are insufficiently comparable as they comprise patients with NCRNNE hepatic metastases from a variety of primary malignancies and consequently overlook differences in tumor behavior, frequency of isolated hepatic metastases, response to neoadjuvant or adjuvant therapy and interval between diagnosis of the primary tumor and the liver metastases. This book, with its more specific approach, will serve not only as an up-to-date guide to diagnosis and treatment but also as a reference on which to base future studies.

This book offers a complete overview on non colorectal non neuroendocrine (NCRNNE) liver metastases and describes in detail the currently available therapies. Each chapter focuses on the treatment of metastases from a particular primary malignancy and also provides valuable information on incidence, natural history and diagnosis. NCRNNE liver metastases are rare entities compared with colorectal and neuroendocrine metastases, for which the treatments are well codified. While more publications have appeared on the topic in recent years, an in-depth study has to date been lacking. Furthermore, most published series are insufficiently comparable as they comprise patients with NCRNNE hepatic metastases from a variety of primary malignancies and consequently overlook differences in tumor behavior, frequency of isolated hepatic metastases, response to neoadjuvant or adjuvant therapy and interval between diagnosis of the primary tumor and the liver metastases. This book, with its more specific approach, will serve not only as an up-to-date guide to diagnosis and treatment but also as a reference on which to base future studies.

This extensive and yet easy-to-read book covers technical aspects of the management of difficult acute cholecystitis. It discusses diagnostic evaluation, treatment, and strategies for avoiding and managing complications based on both evidence-based data and the experiences of the editor and the international contributors. Further, it analyses the latest guidelines to find the best clinical applications. Each chapter describes the current diagnostic and management strategies, focusing on a possible risk stratification by scores proposed in literature. Lastly, the book describes the relevant technical considerations and tips and tricks, explaining them in full. Illustrated throughout and including line graphs depicting fundamental anatomic and technical principles, making it easy-to understand, it is a useful toolkit for all residents, fellows and general surgeons needing a guide to the treatment of difficult acute cholecystits.

Since their first application in 1982, Totally Implantable Venous Access Devices (TIVADs) have become increasingly important in the clinical practice, as more intensive chemotherapy and parenteral treatments have come into use. At this time, there is objective evidence that TIVADs are a safe, effective strategy for long-term venous access; they play a significant role throughout the management of the oncology patient, as they are needed in the initial phases for active treatments as well as in the last stages for palliative measures, making possible repeated administration of chemotherapeutic vesicant agents, nutrients, antibiotics, analgesics, and blood products. According to a number of prospective studies, use of TIVADs is associated with a significant complication rate (10% to 25% of all patients). Evidence-based data support that most complications are directly related to inappropriate technique of placement and/or nursing care, sometimes leading to TIVAD loss, significant morbidity, increased duration of hospitalization, and additional medical cost. A group of world-renowned experts - both in the clinical and research fields - contributed to this volume, whose aim is to provide clinicians, nurses and medical students with a multidisciplinary, full update on these devices, as long term central venous access can no be longer considered a routine matter, and serious complications can be maintained at a very low level only if strict adherence to a well-defined protocol of surgical technique and of catheter care is maintained.

This extensive and yet easy-to-read book covers technical aspects of the management of difficult acute cholecystitis. It discusses diagnostic evaluation, treatment, and strategies for avoiding and managing complications based on both evidence-based data and the experiences of the editor and the international contributors. Further, it analyses the latest guidelines to find the best clinical applications. Each chapter describes the current diagnostic and management strategies, focusing on a possible risk stratification by scores proposed in literature. Lastly, the book describes the relevant technical considerations and tips and tricks, explaining them in full. Illustrated throughout and including line graphs depicting fundamental anatomic and technical principles, making it easy-to understand, it is a useful toolkit for all residents, fellows and general surgeons needing a guide to the treatment of difficult acute cholecystits.